🇺🇸 L-Tyrosine 500 Mg in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 4

Most-reported reactions

1. Application Site Pain — 1 report (25%)
2. Diarrhoea — 1 report (25%)
3. Hypophagia — 1 report (25%)
4. Nausea — 1 report (25%)

Source database →

Frequently asked questions

Is L-Tyrosine 500 Mg approved in United States?

L-Tyrosine 500 Mg does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for L-Tyrosine 500 Mg in United States?

Direction Centrale du Service de Santé des Armées is the originator. The local marketing authorisation holder may differ — check the official source linked above.